Synthesis and Bioactivity Evaluation of a Myelin-Specific Contrast Agent for Magnetic Resonance Imaging of Myelination in Central Nervous System

Bin Wei,Na Weng,Lei Fu,Yuxuan Li,Xu Wang,Ruijuan Yin,Tao Jiang
DOI: https://doi.org/10.1016/j.bmc.2023.117257
2023-03-23
Abstract:Demyelination exists in many neurological diseases of nervous system, such as stroke. Currently, magnetic resonance imaging (MRI) has been the main tool for diagnosing and monitoring the myelin related diseases. However, the conventional MRI unable to distinguish demyelinating lesions from other inflammatory lesions. To address this problem, we have designed and prepared a myelin specific magnetic resonance contrast agent, 6 , which was based myelin specific moiety MeDAS g and Gd-DTPA h . In this work, we verified the specificity and sensitivity of 6 to myelin. Moreover, we investigated the specific binding ability of 6 to myelin sheath in the MCAO mice i models. The in vivo imaging results showed that 6 can bind to the undamaged myelin sheath in the BBB disruption areas, and in turn reduce the relaxation time. The fluorescence images also showed significant fluorescence in the brain right infarct area of the MCAO model mice with administration of 6 . The above results confirmed that 6 could be preferentially distributed in areas with high myelination and can detect focally induced demyelination.
biochemistry & molecular biology,chemistry, medicinal, organic
What problem does this paper attempt to address?